You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. A Tube-Deployed Expendable UAV for Atmospheric Sensing

    SBC: BARRON ASSOCIATES, INC.            Topic: 8213

    NOAA is pursuing sustained, in-situ sensing technology to support improved atmospheric modeling of the upper ocean boundary environment, including the air-sea interface, during turbulent storms. Improved atmospheric modeling in this critical region will lead to better forecasting and support NOAA's mandate to protect property and save lives. Small, unmanned aircraft, equipped with atmospheric sens ...

    SBIR Phase II 2019 Department of CommerceNational Oceanic and Atmospheric Administration
  2. Under Keel Clearance- Risk Management System (UKC-RMS)

    SBC: W R SYSTEMS LTD.            Topic: 828

    The S‐100 specification is a new geospatial standard for hydrographic data, that is presently under development by the International Hydrographic Organization (IHO). Once the S‐100 based products and services are fully developed by the IHO, current datasets will be scheduled for obsolescence, and the Hydrographic Offices (HOs) will no longer produce them. Companies offering e‐navigation solu ...

    SBIR Phase II 2019 Department of CommerceNational Oceanic and Atmospheric Administration
  3. Weather "Action-Chain" Enabler (ACE) Application

    SBC: Blue Storm Associates Inc.            Topic: 834

    In this Phase II effort, PEMDAS Technologies and Innovations (PEMDAS), in collaboration with subcontractor Westover Studios, proposes to develop a functional prototype of the Weather “Action Chain” Enabler (ACE) application using the technologies identified, knowledge gained, and preliminary design conceived during the Phase I effort. As designed, the Weather ACE application will be a non-intr ...

    SBIR Phase II 2019 Department of CommerceNational Oceanic and Atmospheric Administration
  4. Bottom Feeder- A Highly Maneuverable Autonomous Underwater Vehicle

    SBC: Tridentis Advanced Marine Vehicles LLC            Topic: 822

    The Bottom Feeder project is designed to prove out the research done in Phase I using a prototype platform. The prototype will be a full size version of the platform designed during Phase I. The Phase I platform was designed to work in two operational configurations, a highly efficient mode and a highly maneuverable mode, with the ability to switch between them while submerged. The platform is equ ...

    SBIR Phase II 2019 Department of CommerceNational Oceanic and Atmospheric Administration
  5. Rapid Point-of-Care Diagnostics to Detect Serologic Status of Individuals for Select Viral Infections

    SBC: Zymeron Corporation            Topic: NIAID

    CytomegalovirusCMVis a very common intrauterine infectionaffecting approximately one in everychildrenThe overall disease burden in the US with congenital CMV was estimated at $billion annuallyCMV is also a cause of serious morbidity and fatal infections in immunocompromised patientsThere is currently no generally accepted therapy and developing a CMV vaccine is high priorityCurrently CMV trials re ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  6. Improving Spatiotemporal Precision in Noninvasive Electrical Neuromodulation

    SBC: Brain Electrophysiology Laboratory Company, LLC            Topic: 101

    This application describes the commercialization of the Geodesic Transcranial Electrical NeuromodulationGTENtechnology to achieve noninvasive neuromodulation with improved spatiotemporal precisionThe GTEN system enables both EEG source analysis and configurable electrical neuromodulation with theelectrodes of the Geodesic Sensor NetNow in beta release to selected research customersthe GTEN technol ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  7. Whole-organ bioreactor with integrated nondestructive 3D molecular imaging

    SBC: Sonovol, Inc.            Topic: NHLBI

    Abstract SignificanceDonor tissue shortage remains a critical problem in lung transplantationRecent advances in tissue engineering have allowed for the possibility of generating bioengineered lungs from decellularized organ scaffoldsThese scaffoldscreated from the donor s tissuebecome functionalized after recellularization with a patient s own cellsHowevertranslation of whole lung decell recell te ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  8. High Throughput CRISPR/Cas9 cell line generation using the CellRaft Array

    SBC: Cell Microsystems, Inc.            Topic: 400

    Project SummaryGenome editing technologiessuch as CRISPR Casprovide a rapidand targeted means of both knocking out gene expression and knocking in gene modificationsSince our initial Phase I submissionthe utility of CRISPR technology has expanded beyond the generation of cell linesto forward genetic screeningin vivo manipulation of gene expression and even human therapeuticsPhase I efforts success ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  9. Antimicrobial and Biocompatible Endotracheal Tubes

    SBC: Wynnvision LLC            Topic: NHLBI

    Ventilator associated pneumoniaVAPoccurshoursor morefollowing endotracheal intubation and accounts for half of all cases of hospital acquired pneumoniaCDC reports and many clinical studies point to a critical need for preventing ventilator associated infections rather than fighting an often losing battle against acquired infectionResponding to this unmet needWynnVision LLCWVwill leverage strong pr ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  10. Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT

    SBC: Elex Biotech, Inc            Topic: NHLBI

    PROJECT SUMMARY The goal of this project is to complete the preclinical development of Elex Biotechandapos s novel compounds that target and treat the underlying molecular cause of catecholaminergic polymorphic ventricular tachycardiaCPVTCPVTThere are no FDA approved treatments for CPVTa rare genetic disorder affectingindividualswith typical onset in childrenyears of age and no reported difference ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government